HA, G. et al. Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease? iMCD after HHV-8-associated MCD. European Journal of Case Reports in Internal Medicine, v. 10, n. 7, 20 Jun.2023.